This company raised $100 million to bring gene therapy to the masses:
Over the past several years, breakthroughs in gene therapy have led to treatments for rare diseases that were deadly just a decade ago. Take Zolgensma—in 2019, it was the first gene therapy approved by the FDA to treat spinal muscular atrophy, a rare genetic disease that affects the mobility of infants and children. But gene therapies have historically had two drawbacks: They are only used for rare diseases, and they carry a hefty price tag .
“We think this is going to be an extraordinarily important therapeutic class that will revolutionize the treatment of many diseases,” says Jim Momtazee, managing partner at Patient Square Capital. Kriya’s main focus is its uniquely designed Adeno-associated viruses—viruses that are harmless when they enter the body, but deliver instructions to cells that then pump out genes that are missing in some people with genetic diseases. Though the company still plans to develop treatments for rare diseases, what sets it apart is its focus on more common genetic diseases, like some forms of diabetes and obesity.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
This Company Raised $100 Million To Bring Gene Therapy To The MassesKriya Therapeutics plans to use gene therapy to treat common diseases like diabetes and obesity.
Leer más »
Nordstrom’s Sale Has the Best Back-to-School Fashion Under $100From backpacks to sneakers.
Leer más »
Lebanon's army needs $100 million immediately for soldiers' basic needs, general saysLebanon's economy is in freefall after the country failed to form a government.
Leer más »
Shop 19 Stylish Swimsuits Under $100Take your pick between one of these classic, stylish, and on-trend affordable swimsuits
Leer más »
This Company Raised $100 Million To Bring Gene Therapy To The MassesKriya Therapeutics plans to use gene therapy to treat common diseases like diabetes and obesity.
Leer más »